trial

A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients

NCTId NCT00392743
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 60 (actual)
Sponsored by GlaxoSmithKline
Primary completion 2007-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
60 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2006-12
Primary completion
2007-05
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
pet/spect scan

Sponsors

GlaxoSmithKlineLead Sponsor

Sites

7 total
Barcelona, SpainBarcelona, SpainBarcelona, SpainBarcelona, SpainBarcelona, SpainEspluges de Llobregat, SpainSant Boi de Llobregat, Spain

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2007-05
Status
COMPLETED
relationships
The graph out of here
drug
pet/spect scan
drug
lead_sponsor
GlaxoSmithKline
company
indication
Schizophrenia
indication
Schizophrenia
indication